Characterization of Medication Use in a Multicenter Sample of Pediatric Inpatients with Autism Spectrum Disorder.

Journal of Autism and Developmental Disorders
Logan K WinkAutism and Developmental Disorders Inpatient Research Collaborative (ADDIRC)

Abstract

Nearly 11% of youth with Autism Spectrum Disorder (ASD) undergo psychiatric hospitalization, and 65% are treated with psychotropic medication. Here we characterize psychotropic medication usage in subjects enrolled in the Autism Inpatient Collection. Participant psychotropic medication usage rates topped 90% at admission and discharge, though there was a decline at 2-month follow-up. Antipsychotics, ADHD medications, and sleep aids were the most commonly reported classes of medications. The impact of age, gender, and non-verbal IQ on medication usage rates was minimal, though age and IQ may play a role in prescribing practices. Future work is indicated to explore medication usage trends, the impact of clinical factors on medication use rates, and the safety of psychotropic medications in youth with ASD.

References

Aug 2, 2002·The New England Journal of Medicine·James T McCrackenUNKNOWN Research Units on Pediatric Psychopharmacology Autism Network
Jul 9, 2003·Autism : the International Journal of Research and Practice·Cynthia A Molloy, Patricia Manning-Courtney
Aug 20, 2003·Biostatistics·Carolyn M Rutter, Diana L Miglioretti
Nov 9, 2005·Archives of General Psychiatry·UNKNOWN Research Units on Pediatric Psychopharmacology Autism Network
Oct 4, 2007·Pediatric Annals·Craig A EricksonChristopher J McDougle
Nov 3, 2007·Journal of Autism and Developmental Disorders·David S Mandell
Oct 3, 2009·Journal of the American Academy of Child and Adolescent Psychiatry·Ronald N MarcusMichael G Aman
Sep 18, 2010·Current Treatment Options in Neurology·Logan K WinkChristopher J McDougle
Oct 30, 2013·Autism : the International Journal of Research and Practice·Jane R SchubartDouglas Leslie
Nov 16, 2013·Child and Adolescent Psychiatric Clinics of North America·Matthew Siegel, Robin L Gabriels
Mar 13, 2014·Harvard Review of Psychiatry·Laura C PolitteChristopher J McDougle
Apr 30, 2014·Pediatrics·Barbara O McElhanonWilliam G Sharp
Jul 30, 2014·Journal of Autism and Developmental Disorders·Roma A VasaMaria Pilar Bernal
Nov 12, 2015·Molecular Autism·Matthew SiegelUNKNOWN Autism and Developmental Disorders Inpatient Research Collaborative (ADDIRC)
Nov 26, 2015·Journal of the American Academy of Child and Adolescent Psychiatry·Kelly McGuireMatthew Siegel
Apr 1, 2016·MMWR. Surveillance Summaries : Morbidity and Mortality Weekly Report. Surveillance Summaries·Deborah L ChristensenUNKNOWN Centers for Disease Control and Prevention (CDC)
May 31, 2016·Journal of the American Academy of Child and Adolescent Psychiatry·Su Young ParkChristoph U Correll
Jul 7, 2016·Neuropsychiatric Disease and Treatment·Sarah E FitzpatrickCraig A Erickson

❮ Previous
Next ❯

Citations

Nov 25, 2017·Journal of Autism and Developmental Disorders·Kahsi A PedersenMatthew Siegel
Apr 13, 2018·Journal of Autism and Developmental Disorders·Logan K WinkCraig A Erickson
Mar 8, 2019·Psychiatric Services : a Journal of the American Psychiatric Association·Morgan C ShieldsMonika Mitra
Sep 5, 2018·Journal of Autism and Developmental Disorders·Matthew Siegel
Mar 11, 2021·Journal of Psychiatric Research·V NezgovorovaE Hollander
Apr 6, 2021·Autism Research : Official Journal of the International Society for Autism Research·Caitlin M ConnerCarla A Mazefsky

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Autism

Autism spectrum disorder is associated with challenges with social skills, repetitive behaviors, and often accompanied by sensory sensitivities and medical issues. Here is the latest research on autism.

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.

Related Papers

JAMA : the Journal of the American Medical Association
J J Staudenmeier, I Jacoby
JAMA : the Journal of the American Medical Association
S S RathoreJ J Gonzales
JAMA : the Journal of the American Medical Association
M B BowersC M Mazure
JAMA Pediatrics
Kathleen R MerikangasMark Olfson
© 2022 Meta ULC. All rights reserved